Behzad Aghazadeh is Director & 10% Owner at IMMUNOMEDICS INC (IMMU). They have made 9 open-market trades across 3 companies since 2017, most recently 2026-07-28.
CIK 0001701815
6 open-market purchases totalling $164.3M since 2017, against 3 sales. Across 5 scored buys the stock is up 11.9% at ninety days, and 8.8 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMMU | 26,250,000 | $2.3B |
| MRTX | 3,800,000 | $223.1M |
| SCTX | 3,088,888 | $62.5M |
| AADI | 2,211,752 | $4.5M |
| CBAY | 300 | $10K |
| Total | $2.6B |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 83% | 60% |
| Avg Move | +7.6% | +13.2% | +11.9% |
| Alpha | +6.7% | +9.6% | +8.8% |
| Scored | 6 | 6 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SCTX | BUY | 2026-07-24 | 2026-07-28 | $15.16 | $36.3M | +44.0% | +56.9% | — |
| IMMU | BUY | 2020-05-01 | 2020-05-01 | $28.50 | $49.9M | +4.2% | +8.6% | +40.9% |
| IMMU | BUY | 2019-12-05 | 2019-12-09 | $17.50 | $35.0M | -6.9% | -5.3% | -30.0% |
| MRTX | SELL | 2019-07-23 | 2019-07-25 | $101.88 | $6.4M | +0.7% | -11.7% | -19.1% |
| MRTX | SELL | 2019-03-18 | 2019-03-20 | $74.40 | $27.7M | -3.1% | -13.8% | +42.2% |
| MRTX | SELL | 2019-02-20 | 2019-02-21 | $73.00 | $50.1M | -4.2% | +0.1% | +1.4% |
| IMMU | BUY | 2018-06-15 | 2018-06-15 | $24.00 | $13.8M | -1.3% | +8.6% | -3.6% |
| MRTX | BUY | 2018-06-11 | 2018-06-12 | $38.85 | $15.5M | +11.5% | +5.8% | +19.4% |
| IMMU | BUY | 2017-11-14 | 2017-11-15 | $10.47 | $13.9M | -6.2% | +4.5% | +33.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.